Acute exercise-induced response of monocyte subtypes in chronic heart and renal failure

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Van Craenenbroeck, Amaryllis H ^a,b   Van Ackeren, Katrijn ^b   Hoymans, Vicky Y ^a,b   Roeykens, Johan ^a   Verpooten, Gert A ^a   Vrints, Christiaan J ^a,b   Couttenye, Marie M ^a,b   Van Craenenbroeck, Emeline M ^a,b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; CCL2 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ADULT; AEROBIC EXERCISE; ARTICLE; BODY MASS; CARDIOPULMONARY EXERCISE TEST; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HEMODYNAMICS; HUMAN; KIDNEY FAILURE; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MONOCYTE; NEUTROPHIL COUNT; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; ANGIOGENESIS; BLOOD; CHRONIC KIDNEY FAILURE; CYTOLOGY; EXERCISE TEST; INFLAMMATION; MIDDLE AGED; NORMAL HUMAN;

ADULT; BODY MASS INDEX; CHEMOKINE CCL2; EXERCISE; EXERCISE TEST; FEMALE; FLOW CYTOMETRY; GLOMERULAR FILTRATION RATE; HEALTHY VOLUNTEERS; HEART FAILURE; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MONOCYTES; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 84920520510     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/216534     Document Type: Article

References (41)

1. A. M. Zawada, K. S. Rogacev, B. Rotter et al., "SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset, " Blood, vol. 118, no. 12, pp. e50-e61, 2011.
2. L. Ziegler-Heitbrock, P. Ancuta, S. Crowe et al., "Nomenclature of monocytes and dendritic cells in blood, " Blood, vol. 116, no. 16, pp. e74-e80, 2010.
3. E. Shantsila, B. Wrigley, L. Tapp et al., "Immunophenotypic characterization of human monocyte subsets: possible implications for cardiovascular disease pathophysiology, " Journal of Thrombosis and Haemostasis, vol. 9, no. 5, pp. 1056-1066, 2011.
4. B. J. Wrigley, G. Y. Lip, and E. Shantsila, "The role of monocytes and inflammation in the pathophysiology of heart failure, " European Journal of Heart Failure, vol. 13, no. 11, pp. 1161-1171, 2011.
5. A. Tedgui and Z. Mallat, "Cytokines in atherosclerosis: pathogenic and regulatory pathways, " Physiological Reviews, vol. 86, no. 2, pp. 515-581, 2006.
6. R. T. Gansevoort, R. Correa-Rotter, B. R. Hemmelgarn et al., "Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention, "TheLancet, vol. 382, no. 9889, pp. 339-352, 2013.
7. V.M. Conraads, J. M. Bosmans, and C. J. Vrints, "Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia, " International Journal of Cardiology, vol. 85, no. 1, pp. 33-49, 2002.
8. U.G. Bronas, "Exercise training and reduction of cardiovascular disease risk factors in patients with chronic kidney disease, " Advances in Chronic Kidney Disease, vol. 16, no. 6, pp. 449-458, 2009.
9. C. M. OConnor, D. J. Whellan, K. L. Lee et al., "Efficacy and safety of exercise training in patients with chronic heart failure HF-ACTION randomized controlled trial, " The Journal of the American Medical Association, vol. 301, no. 14, pp. 1439-1450, 2009.
10. S. Adamopoulos, J. Parissis, C. Kroupis et al., "Physical training reduces peripheral markers of inflammation in patients with chronic heart failure, " European Heart Journal, vol. 22, no. 9, pp. 791-797, 2001.
11. J. L. Viana, G. C. Kosmadakis, E. L. Watson et al., "Evidence for anti-inflammatory effects of exercise in CKD, " Journal of the American Society of Nephrology, 2014.
12. H. Gabriel, A. Urhausen, L. Brechtel, H.-J. Muller, and W. Kindermann, "Alterations of regular and mature monocytes are distinct, and dependent of intensity and duration of exercise, " European Journal of Applied Physiology and Occupational Physiology, vol. 69, no. 2, pp. 179-181, 1994.
13. M. J. Hubal, T. C. Chen, P. D.Thompson, and P. M. Clarkson, "Inflammatory gene changes associated with the repeatedbout effect, " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 294, no. 5, pp. R1628-R1637, 2008.
14. A. Steensberg, G. van Hall, T. Osada, M. Sacchetti, B. Saltin, and B. K. Pedersen, "Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6, " The Journal of Physiology, vol. 529, part 1, pp. 237-242, 2000.
15. U. R. Mikkelsen, C. Couppé, A. Karlsen et al., "Life-long endurance exercise in humans: circulating levels of inflammatory markers and leg muscle size, " Mechanisms of Ageing and Development, vol. 134, no. 11-12, pp. 531-540, 2014.
16. E. Shantsila, L.D. Tapp, B. J. Wrigley et al., "The effects of exercise and diurnal variation onmonocyte subsets andmonocyteplatelet aggregates, " European Journal of Clinical Investigation, vol. 42, no. 8, pp. 832-839, 2012.
17. J. E. Hansen, D. Y. Sue, and K. Wasserman, "Predicted values for clinical exercise testing, "TheAmerican Review of Respiratory Disease, vol. 129, no. 2, pp. S49-S55, 1984.
18. A. S. Levey, L. A. Stevens, C. H. Schmid et al., "Anewequation to estimate glomerular filtration rate, " Annals of InternalMedicine, vol. 150, no. 9, pp. 604-612, 2009.
19. A. Schlitt, G. H. Heine, S. Blankenberg et al., "CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF- levels, "Thrombosis and Haemostasis, vol. 92, no. 2, pp. 419-424, 2004.
20. M. A.Venneri, M. de Palma, M. Ponzoni et al., "Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer, " Blood, vol. 109, no. 12, pp. 5276- 5285, 2007.
21. S. Fujiyama, K. Amano, K. Uehira et al., "Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells, " Circulation Research, vol. 93, no. 10, pp. 980-989, 2003.
22. K. L.Wong, J. J.-Y. Tai, W.-C.Wong et al., "Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets, " Blood, vol. 118, no. 5, pp. e16-e31, 2011.
23. K. S. Rogacev, S. Seiler, A. M. Zawada et al., "CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease, " European Heart Journal, vol. 32, no. 1, pp. 84- 92, 2011.
24. K. S. Rogacev, B. Cremers, A. M. Zawada et al., "CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography, " Journal of theAmerican College of Cardiology, vol. 60, no. 16, pp. 1512-1520, 2012.
25. B. J. Wrigley, E. Shantsila, L. D. Tapp, and G. Y. H. Lip, "CD14++CD16+ monocytes in patients with acute ischaemic heart failure, " European Journal of Clinical Investigation, vol. 43, no. 2, pp. 121-130, 2013.
26. C. Barisione, S. Garibaldi, G. Ghigliotti et al., "CD14CD16monocyte subset levels in heart failure patients, " Disease Markers, vol. 28, no. 2, pp. 115-124, 2010.
27. O. Amir, I. Spivak, I. Lavi, and M. A. Rahat, "Changes in the monocytic subsets CD14dimCD16+ and CD14++CD16? in chronic systolic heart failure patients, " Mediators of Inflammation, vol. 2012, Article ID 616384, 9 pages, 2012.
28. A. M. Zawada, K. S. Rogacev, S. H. Schirmer et al., "Monocyte heterogeneity in human cardiovascular disease, " Immunobiology, vol. 217, no. 12, pp. 1273-1284, 2012.
29. M.Vaduganathan, S. J.Greene, J. Butler et al., "The immunological axis in heart failure: importance of the leukocyte differential, " Heart Failure Reviews, vol. 18, no. 6, pp. 835-845, 2013.
30. J. G. Wheeler, M. E. Mussolino, R. F. Gillum, and J. Danesh, "Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases fromseven prospective studies of 30 374 individuals, " European Heart Journal, vol. 25, no. 15, pp. 1287-1292, 2004.
31. B. Steppich, F. Dayyani, R. Gruber, R. Lorenz, M. Mack, and H. W. L. Ziegler-Heitbrock, "Selective mobilization of CD14+ CD16+ monocytes by exercise, "The American Journal of Physiology- Cell Physiology, vol. 279, no. 3, pp. C578-C586, 2000.
32. I. Heimbeck, T. P. J. Hofer, C. Eder et al., "Standardized singleplatform assay for human monocyte subpopulations: lower CD14+CD16++ monocytes in females, " Cytometry A, vol. 77, no. 9, pp. 823-830, 2010.
33. R. J. Simpson, B. K. McFarlin, C. McSporran, G. Spielmann, B. O. Hartaigh, and K. Guy, "Toll-like receptor expression on classic and pro-inflammatory bloodmonocytes after acute exercise in humans, " Brain, Behavior, and Immunity, vol. 23, no. 2, pp. 232-239, 2009.
34. P. Ancuta, R. Rao, A. Moses et al., "Fractalkine preferentially mediates arrest and migration of CD16+ monocytes, " The Journal of Experimental Medicine, vol. 197, no. 12, pp. 1701-1707, 2003.
35. S.Hong and P. J.Mills, "Effects of an exercise challenge onmobilization and surface marker expression of monocyte subsets in individuals with normal versus elevated blood pressure, " Brain, Behavior, and Immunity, vol. 22, no. 4, pp. 590-599, 2008.
36. S. Heiwe and S. H. Jacobson, "Exercise training for adults with chronic kidney disease, " Cochrane Database of Systematic Reviews, no. 10, Article ID CD003236, 2011.
37. F. B. Mayr, A. O. Spiel, J. M. Leitner et al., "Influence of the Duffy antigen on pharmacokinetics and pharmacodynamics of recombinantmonocyte chemoattractant protein (MCP-1, CCL- 2) in vivo, " International Journal of Immunopathology and Pharmacology, vol. 22, no. 3, pp. 615-625, 2009.
38. S. Raschke and J. Eckel, "Adipo-Myokines: two sides of the same coin-mediators of inflammation and mediators of exercise, " Mediators of Inflammation, vol. 2013, Article ID 320724, 16 pages, 2013.
39. J.M. Peake, K. Suzuki, M. Hordern, G. Wilson, K.Nosaka, and J. S. Coombes, "Plasma cytokine changes in relation to exercise intensity and muscle damage, " European Journal of Applied Physiology, vol. 95, no. 5-6, pp. 514-521, 2005.
40. M.Gleeson, N.C. Bishop, D. J. Stensel, M. R. Lindley, S. S. Mastana, and M. A.Nimmo, "The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease, " Nature Reviews Immunology, vol. 11, no. 9, pp. 607-615, 2011.
41. C. P. Fischer, "Interleukin-6 in acute exercise and training: what is the biological relevance?" Exercise Immunology Review, vol. 12, pp. 6-33, 2006.